Not applicableStudy completedNCT02708537What this trial is testingEffect of Plasma Rich in Growth Factors on Semen QualityWho this might be right forVascular Endothelial Growth Factor Overexpression IVI Bilbao 20
Not applicableEnded earlyNCT02823262What this trial is testingA Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderWho this might be right forBreast CancerEstrogen Receptor Positive Breast CancerNode-negative Breast Cancer+1 more Beth Israel Deaconess Medical Center 65
Not applicableStudy completedNCT02883127What this trial is testingMotivational Interviewing With Focus on Diet and Weight Gain in Pregnant Women With Type 2 DiabetesWho this might be right forType 2 DiabetesPregnancy Rigshospitalet, Denmark 189
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754123What this trial is testingPhase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCWho this might be right forAdvanced or Metastatic NSCLC Jiangsu Hansoh Pharmaceutical Co., Ltd. 206
Testing effectiveness (Phase 2)Looking for participantsNCT07796880What this trial is testingNeoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast CancerWho this might be right forHormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Early research (Phase 1)Study completedNCT00685854What this trial is testingRanibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel GrowthWho this might be right forMacular Telangiectasia National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Study completedNCT00109941What this trial is testingOpioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryWho this might be right forPancreatic Cancer Milton S. Hershey Medical Center 25
Early research (Phase 1)Study completedNCT00702494What this trial is testingPhase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid TumoursWho this might be right forSolid Tumors BioInvent International AB 21
Not applicableStudy completedNCT00970970What this trial is testingVisualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau DiseaseWho this might be right forVon Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more University Medical Center Groningen 22
Early research (Phase 1)UnknownNCT04363242What this trial is testingFind the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR ExpressionsWho this might be right forEpithelial CarcinomaSolid Tumor Synermore Biologics Co., Ltd. 22
Not applicableStudy completedNCT03324542What this trial is testingReal World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in TaiwanWho this might be right forAMD Changhua Christian Hospital 63
Testing effectiveness (Phase 2)UnknownNCT04009473What this trial is testingStem Cell Therapy and Growth Factor Ovarian in Vitro ActivationWho this might be right forMenopauseMenopause Ovarian FailureOvarian Failure+21 more Forever Young d.o.o. 100
Not applicableUnknownNCT04158505What this trial is testingReal World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast CancerWho this might be right forHER2-positive Breast Cancer Chinese Academy of Medical Sciences 3,000
Testing effectiveness (Phase 2)Study completedNCT00410696What this trial is testingPegfilgrastim Versus Filgrastim After High-dose ChemotherapyWho this might be right forHematological NeoplasmsTumors Armando Santoro, MD 80
Large-scale testing (Phase 3)Study completedNCT04093583What this trial is testingRandomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.Who this might be right forDental Implantation Fundación Eduardo Anitua 46
Early research (Phase 1)Active Not RecruitingNCT05364073What this trial is testingStudy of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) MutationsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer+3 more ArriVent BioPharma, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02119520What this trial is testingPLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITISWho this might be right forPeriodontitis Government Dental College and Research Institute, Bangalore 96
Early research (Phase 1)UnknownNCT02691871What this trial is testingApatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFRWho this might be right forLung Adenocarcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Post-approval studies (Phase 4)Ended earlyNCT04731233What this trial is testingEfficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ OsteoarthritisWho this might be right forTMJOsteoarthritis University of Florida 5
Post-approval studies (Phase 4)Study completedNCT01609543What this trial is testingTarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR MutationsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 62